COLUMBIA, SC--(Marketwire - July 17, 2008) - BDI, a national leader in the distribution of biopharmaceutical products, announced that sales for the first two quarters of 2008 continued to demonstrate an increase of more than twenty percent (20%) in comparison to same time period in 2007. With a history of strong third and fourth quarter sales, BDI projects that year end revenues, which have grown at an average rate of twenty-three percent (23%) per year from 2004 - 2007, will meet or surpass expectations for the current fiscal year.
